Obesity exerts its effects on the endometrium via three processes primarily, i.e., increased insulin (secondary to insulin resistance), increased aromatase, and imbalanced adipokines (increased leptin, decreased adiponectin), pretty much as is the case with the breast 83, 84. Here, CYP19A1 is linked to obesity due to melanocortin 4 receptor deficiency.